360 Results for "

HDAC6

" in MedChemExpress (MCE) Product Catalog:
Products (360)

360 Results for "HDAC6" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
171
171 Publications Verification
Cat. No.: HY-10221
CAS No.: 149647-78-9
Purity:  99.58%
Synonyms: SAHA; Suberoylanilide hydroxamic acid
Research Areas:  

Infection Cancer

Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC6 and HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis . Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification .
loading...
    loading...
75
75 Cited Publications
Cat. No.: HY-15149
CAS No.: 128517-07-7
Purity:  99.87%
Synonyms: FK 228; FR 901228; NSC 630176
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Romidepsin (FK 228) is a Histone deacetylase (HDAC) inhibitor with anti-tumor activities. Romidepsin (FK 228) inhibits HDAC1, HDAC2, HDAC4, and HDAC6 with IC50s of 36 nM, 47 nM, 510 nM and 1.4 μM, respectively . Romidepsin (FK 228) is produced by Chromobacterium violaceum, induces cell G2/M phase arrest and apoptosis .
loading...
    loading...
47
47 Cited Publications
Cat. No.: HY-16026
CAS No.: 1316214-52-4
Synonyms: ACY-1215; Rocilinostat
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Ricolinostat (ACY-1215) is a potent and selective HDAC6 inhibitor, with an IC50 of 5 nM. ACY-1215 also inhibits HDAC1, HDAC2, and HDAC3 with IC50s of 58, 48, and 51 nM, respectively.
loading...
    loading...
42
42 Cited Publications
Cat. No.: HY-13271A
CAS No.: 1252003-15-8
Purity:  98.37%
Research Areas:  

Cancer

Tubastatin A is a potent and selective HDAC6 inhibitor with an IC50 of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). Tubastatin A also inhibits HDAC10 and metallo-β-lactamase domain-containing protein 2 (MBLAC2).
loading...
    loading...
42
42 Cited Publications
Cat. No.: HY-13271
CAS No.: 1310693-92-5
Purity:  99.29%
Synonyms: Tubastatin A HCl; TSA HCl
Research Areas:  

Cancer

Tubastatin A Hydrochloride (Tubastatin A HCl) is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). Tubastatin A Hydrochloride also inhibits HDAC10 and metallo-β-lactamase domain-containing protein 2 (MBLAC2).
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-18998
CAS No.: 1418033-25-6
Target:  

HDAC

Research Areas:  

Cancer

LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-13428
CAS No.: 537049-40-4
Purity:  99.54%
Research Areas:  

Cancer

Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1. Tubacin also inhibits metallo-β-lactamase domain-containing protein 2 (MBLAC2).
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-12164
CAS No.: 726169-73-9
Purity:  99.13%
Synonyms: MGCD0103
Target:  

HDAC Autophagy Apoptosis

Research Areas:  

Cancer

Mocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC50s of 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC8.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-100871
CAS No.: 1206731-57-8
Purity:  98.36%
Research Areas:  

Cancer

WT-161 is a potent and selective HDAC6 inhibitor with an IC50 of 0.40 nM . WT-161 also inhibits metallo-β-lactamase domain-containing protein 2 (MBLAC2) .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-19327
CAS No.: 1375465-91-0
Target:  

HDAC

Research Areas:  

Cancer

ACY-738 is a potent, selective and orally-bioavailable HDAC6 inhibitor, with an IC50 of 1.7 nM; ACY-738 also inhibits HDAC1, HDAC2, and HDAC3, with IC50s of 94, 128, and 218 nM.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-18613
CAS No.: 1045792-66-2
Synonyms: BML-281
Target:  

HDAC

Research Areas:  

Cancer

CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-14718A
CAS No.: 1187075-34-8
Purity:  99.68%
Synonyms: RAS2410 hydrochloride; 4SC-201 hydrochloride
Target:  

HDAC

Research Areas:  

Cancer

Resminostat hydrochloride is a potent inhibitor of HDAC1, HDAC3 and HDAC6, with mean IC50 values of 42.5, 50.1, 71.8 nM, respectively, and shows less potent activities against HDAC8, with an IC50 of 877 nM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-14718
CAS No.: 864814-88-0
Purity:  99.84%
Synonyms: RAS2410; 4SC-201
Target:  

HDAC

Research Areas:  

Cancer

Resminostat (RAS2410; 4SC-201) is a potent inhibitor of HDAC1, HDAC3 and HDAC6, with mean IC50 values of 42.5, 50.1, 71.8 nM, respectively, and shows less potent activities against HDAC8, with an IC50 of 877 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-18700
CAS No.: 1440209-96-0
Target:  

HDAC

Research Areas:  

Cancer

BRD73954 is a potent HDAC inhibitor and selectively inhibiting both HDAC6 and HDAC8 with IC50 values of 0.0036, 0.12, 9, 12, 23 µM for HDAC6, HDAC8, HDAC2, HDAC1 and HDAC3, respectively. BRD73954 decreases the levels of HDAC6, associated with upregulation of Ac-Tubulin .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-115475
CAS No.: 2126744-35-0
Purity:  99.93%
Target:  

HDAC

Research Areas:  

Neurological Disease

SW-100, a selective histone deacetylase 6 (HDAC6) inhibitor with an IC50 of 2.3 nM, shows at least 1000-fold selectivity for HDAC6 relative to all other HDAC isozymes. SW-100 displays a significantly improved ability to cross the blood-brain-barrier .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101780
CAS No.: 1236199-60-2
Purity:  99.64%
Synonyms: EDO-S101; NL-101
Target:  

HDAC

Research Areas:  

Cancer

Tinostamustine (EDO-S101) is a pan HDAC inhibitor; inhibits HDAC6, HDAC1, HDAC2 and HDAC3 with IC50 values of 6 nM, 9 nM, 9 nM and 25 nM, respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15994
CAS No.: 1316215-12-9
Synonyms: ACY241
Target:  

HDAC

Research Areas:  

Cancer

Citarinostat (ACY241) is a second generation potent, orally active and high-selective HDAC6 inhibitor with an IC50 of 2.6 nM (IC50s of 35 nM, 45 nM, 46 nM and 137 nM for HDAC1, HDAC2, HDAC3 and HDAC8, respectively). Citarinostat has anticancer effects .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13267
CAS No.: 99873-43-5
Purity:  98.91%
Synonyms: NS 41080
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Droxinostat (NS 41080) is a histone deacetylase (HDAC) inhibitor. Droxinostat selectively inhibits HDAC3, HDAC6, and HDAC8 with IC50 values of 16.9 μM, 2.47 μM, and 1.46 μM, respectively. Droxinostat can be used for the research of hepatocellular carcinoma (HCC) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-18712
CAS No.: 926259-99-6
Target:  

HDAC Apoptosis Caspase

Research Areas:  

Cancer

BG45 is a potent HDAC3 inhibitor with IC50 values of 0.289, 2, 2.2 and ﹥20 μM for HDAC3, HDAC1, HDAC2 and HDAC6, respectively. BG45 selectively targets multiple myeloma (MM) cells and induces caspase-dependent apoptosis .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13432
CAS No.: 1256448-47-1
Purity:  99.34%
Synonyms: CHR-3996
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Nanatinostat (CHR-3996) is a potent, class I selective and orally active HDAC inhibitor with IC50s of 3 nM, 4 nM, and 7 nM for HDAC1, HDAC2, and HDAC3, respectively. Nanatinostat has low activity against HDAC5 (IC50 of 200 nM) and HDAC6 (IC50 of 2100 nM). Nanatinostat induces apoptosis in myeloma cells. Nanatinostat has potent anticancer effects, such as myeloma, advanced solid tumours and colorectal cancer .
loading...
    loading...